Article covers a study published in the BMJ and co-authored by ISMP senior scientist that calculated a median pivotal clinical trial cost for new drugs in development, and offers a breakdown of possible factors leading to those costs.
For the full text, visit Endpoints News online.
More News
Since the 2021-2022 influenza (flu) vaccine became available in September, the Institute for Safe Medication Practices (ISMP) has received multiple reports of mix-ups. Some patients have consented to a flu vaccine but received one of the COVID-19 vaccines instead, while others have received the flue
This news brief appeared in the OR Manager newsletter on September 16, 2021.
ECRI and its affiliate, the Institute for Safe Medication Practices (ISMP), advocate for safe maternal and newborn care; launches site with free resources and safety guidance.